Learn More
TARGETMOL CHEMICALS INC BMS-P5 free base 10MG

Supplier: TARGETMOL CHEMICALS INC T22277L10MG
Also available in 1 mL, 5 mg, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor that blocks the formation of Neutrophil Extracellular Traps and delays the progression of multiple myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays symptom onset and disease progression. Targeting PAD4 may be beneficial for treating multiple myeloma. Purity 99.96%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.